Get started
Author

Rhea Micci Simons

Observed names: Rhea M Simons, Rhea M. Simons, Rhea Simons
ORCID: 0009-0009-3300-2575
Observed ORCID: 0009-0009-3300-2575
OpenAlex ID: A5037579638
Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
2015 · Natasha B. Halasa, Bipin N. Savani, et al. · Transplantation and Cellular Therapy · 69
PDF
Management Principles Associated With Cytokine Release Syndrome
2019 · Brittney Baer, Channing Vail Dudley, et al. · Seminars in Oncology Nursing · 11
Utilization of Chimeric Antigen Receptor T-cell Therapy in Adults
2019 · Channing Vail Dudley, Brittney Baer, et al. · Seminars in Oncology Nursing · 6
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al. · Clinical Cancer Research · 5
A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab As Maintenance Therapy Following R-CHOP Chemotherapy for Patients with High Risk Diffuse Large B-Cell Lymphoma
2012 · Nishitha M. Reddy, Rhea M Simons, et al. · Blood · 4
Data from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al. · 1
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2025 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Data from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in patients with Myelofibrosis
2024 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in patients with Myelofibrosis
2024 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in patients with Myelofibrosis
2024 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Data from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Data from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023 · Tamara K. Moyo, Ashwin Kishtagari, et al.
Works count: 16
Citation count: 96
H-index: 4
I10-index: 2
Year
Topic
Type